4.29 USD
-0.23 (-5.09%)
4.6 USD
+0.31 (+7.23%)
SBC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. SBC has an excellent financial health rating, but there are some minor concerns on its profitability. SBC is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
SBC had positive earnings in the past year.
In the past year SBC has reported a negative cash flow from operations.
1.2 Ratios
With an excellent Return On Assets value of 13.48%, SBC belongs to the best of the industry, outperforming 98.04% of the companies in the same industry.
The Return On Equity of SBC (17.47%) is better than 83.33% of its industry peers.
SBC's Return On Invested Capital of 21.24% is amongst the best of the industry. SBC outperforms 93.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.48% | ||
| ROE | 17.47% | ||
| ROIC | 21.24% |
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SBC has a better Profit Margin (24.28%) than 100.00% of its industry peers.
SBC has a better Operating Margin (41.70%) than 100.00% of its industry peers.
SBC's Gross Margin of 74.09% is amongst the best of the industry. SBC outperforms 89.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 41.7% | ||
| PM (TTM) | 24.28% | ||
| GM | 74.09% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SBC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, SBC has less shares outstanding
Compared to 1 year ago, SBC has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 6.59 indicates that SBC is not in any danger for bankruptcy at the moment.
SBC has a Altman-Z score of 6.59. This is amongst the best in the industry. SBC outperforms 89.22% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that SBC is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.07, SBC is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.59 |
ROIC/WACC2.42
WACC8.78%
2.3 Liquidity
A Current Ratio of 5.10 indicates that SBC has no problem at all paying its short term obligations.
With an excellent Current ratio value of 5.10, SBC belongs to the best of the industry, outperforming 93.14% of the companies in the same industry.
SBC has a Quick Ratio of 5.06. This indicates that SBC is financially healthy and has no problem in meeting its short term obligations.
SBC's Quick ratio of 5.06 is amongst the best of the industry. SBC outperforms 93.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.1 | ||
| Quick Ratio | 5.06 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 48.69% over the past year.
The Revenue has grown by 10.85% in the past year. This is quite good.
EPS 1Y (TTM)48.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)10.85%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.33%
3.2 Future
Based on estimates for the next years, SBC will show a decrease in Earnings Per Share. The EPS will decrease by -0.28% on average per year.
The Revenue is expected to decrease by -0.61% on average over the next years.
EPS Next Y-26.89%
EPS Next 2Y-8.33%
EPS Next 3Y-0.28%
EPS Next 5YN/A
Revenue Next Year-17.44%
Revenue Next 2Y-6.07%
Revenue Next 3Y-0.61%
Revenue Next 5YN/A
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 7.94 indicates a rather cheap valuation of SBC.
Based on the Price/Earnings ratio, SBC is valued cheaply inside the industry as 96.08% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.61, SBC is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.50, the valuation of SBC can be described as reasonable.
Based on the Price/Forward Earnings ratio, SBC is valued cheaper than 95.10% of the companies in the same industry.
SBC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.01.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.94 | ||
| Fwd PE | 8.5 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SBC is valued cheaply inside the industry as 95.10% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 4.34 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.33%
EPS Next 3Y-0.28%
5. Dividend
5.1 Amount
No dividends for SBC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
4.29
-0.23 (-5.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners0.83%
Inst Owner ChangeN/A
Ins Owners90.38%
Ins Owner Change0%
Market Cap440.07M
Revenue(TTM)178.46M
Net Income(TTM)43.32M
Analysts80
Price Target8.33 (94.17%)
Short Float %1.46%
Short Ratio3.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-38.66%
Min EPS beat(2)-85.33%
Max EPS beat(2)8.01%
EPS beat(4)3
Avg EPS beat(4)5.59%
Min EPS beat(4)-85.33%
Max EPS beat(4)89.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.07%
Min Revenue beat(2)-4.16%
Max Revenue beat(2)-3.99%
Revenue beat(4)0
Avg Revenue beat(4)-9.96%
Min Revenue beat(4)-22.64%
Max Revenue beat(4)-3.99%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.38%
EPS NQ rev (1m)4.35%
EPS NQ rev (3m)0%
EPS NY rev (1m)0.39%
EPS NY rev (3m)-1.14%
Revenue NQ rev (1m)-1.42%
Revenue NQ rev (3m)-1.3%
Revenue NY rev (1m)-1.13%
Revenue NY rev (3m)-1.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.94 | ||
| Fwd PE | 8.5 | ||
| P/S | 2.47 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.77 | ||
| P/tB | 2 | ||
| EV/EBITDA | 4.34 |
EPS(TTM)0.54
EY12.59%
EPS(NY)0.51
Fwd EY11.77%
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS1.74
BVpS2.42
TBVpS2.14
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.42
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.48% | ||
| ROE | 17.47% | ||
| ROCE | 26.89% | ||
| ROIC | 21.24% | ||
| ROICexc | 39.36% | ||
| ROICexgc | 48.54% | ||
| OM | 41.7% | ||
| PM (TTM) | 24.28% | ||
| GM | 74.09% | ||
| FCFM | N/A |
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.24 | ||
| Cap/Depr | 69.08% | ||
| Cap/Sales | 1.14% | ||
| Interest Coverage | 636.56 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.1 | ||
| Quick Ratio | 5.06 | ||
| Altman-Z | 6.59 |
F-Score5
WACC8.78%
ROIC/WACC2.42
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y-26.89%
EPS Next 2Y-8.33%
EPS Next 3Y-0.28%
EPS Next 5YN/A
Revenue 1Y (TTM)10.85%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.33%
Revenue Next Year-17.44%
Revenue Next 2Y-6.07%
Revenue Next 3Y-0.61%
Revenue Next 5YN/A
EBIT growth 1Y14.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-14%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1928.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1816.19%
OCF growth 3YN/A
OCF growth 5YN/A
SBC MEDICAL GROUP HOLDINGS I / SBC FAQ
What is the fundamental rating for SBC stock?
ChartMill assigns a fundamental rating of 5 / 10 to SBC.
What is the valuation status for SBC stock?
ChartMill assigns a valuation rating of 5 / 10 to SBC MEDICAL GROUP HOLDINGS I (SBC). This can be considered as Fairly Valued.
How profitable is SBC MEDICAL GROUP HOLDINGS I (SBC) stock?
SBC MEDICAL GROUP HOLDINGS I (SBC) has a profitability rating of 5 / 10.
Can you provide the financial health for SBC stock?
The financial health rating of SBC MEDICAL GROUP HOLDINGS I (SBC) is 7 / 10.
What is the expected EPS growth for SBC MEDICAL GROUP HOLDINGS I (SBC) stock?
The Earnings per Share (EPS) of SBC MEDICAL GROUP HOLDINGS I (SBC) is expected to decline by -26.89% in the next year.